Hu JD - Search Results

1

Dihydroisotanshinone I regulates ferroptosis via PI3K/AKT pathway to enhance cisplatin sensitivity in lung adenocarcinoma.

Li FJ, Gao LC, Long HZ, Zhou ZW, Luo HY, Xu SG, Dai SM, Hu JD. Li FJ, et al. Among authors: hu jd. J Pharm Pharmacol. 2024 Jul 23:rgae085. doi: 10.1093/jpp/rgae085. Online ahead of print. J Pharm Pharmacol. 2024. PMID: 39045884

2

The important role of miR-1-3p in cancers.

Dai S, Li F, Xu S, Hu J, Gao L. Dai S, et al. J Transl Med. 2023 Oct 31;21(1):769. doi: 10.1186/s12967-023-04649-8. J Transl Med. 2023. PMID: 37907984 Free PMC article. Review.

3

Pharmacokinetic and Safety Study of Bismuth Potassium Citrate Formulations in Healthy Subjects.

Luo HY, Xu SG, Gao LC, Long HZ, Zhou ZW, Li FJ, Dai SM, Hu JD, Su Y, Cheng Y. Luo HY, et al. Among authors: hu jd. Drugs R D. 2024 Mar;24(1):81-87. doi: 10.1007/s40268-024-00455-9. Epub 2024 Feb 12. Drugs R D. 2024. PMID: 38345697 Free PMC article.

4

Isoliensinine suppressed gastric cancer cell proliferation and migration by targeting TGFBR1 to regulate TGF-β-smad signaling pathways.

Hu J, Dai S, Yuan M, Li F, Xu S, Gao L. Hu J, et al. Front Pharmacol. 2024 Sep 19;15:1438161. doi: 10.3389/fphar.2024.1438161. eCollection 2024. Front Pharmacol. 2024. PMID: 39364054 Free PMC article.

5

Circulating levels of micronutrients and the risk of benign paroxysmal positional vertigo: A Mendelian randomization study.

Wang J, Cao C, Jiang WB, Sun HC, Jiang T, Hu JD. Wang J, et al. Among authors: hu jd. Heliyon. 2024 Oct 2;10(19):e38782. doi: 10.1016/j.heliyon.2024.e38782. eCollection 2024 Oct 15. Heliyon. 2024. PMID: 39430529 Free PMC article.

6

Isoliensinine activated the Nrf2/GPX4 pathway to inhibit glutamate-induced ferroptosis in HT-22 cells.

Long HZ, Li FJ, Gao LC, Zhou ZW, Luo HY, Xu SG, Dai SM, Hu JD. Long HZ, et al. Among authors: hu jd. J Biochem Mol Toxicol. 2024 Sep;38(9):e23794. doi: 10.1002/jbt.23794. J Biochem Mol Toxicol. 2024. PMID: 39163615

7

[Genetic diversity of SP1 population of space mutagenized Pueraria montana].

Hu JD, Dong LH, Zhu WF, Wang B, Chen YM, Wang XY, Zhu YY, Ge F. Hu JD, et al. Zhongguo Zhong Yao Za Zhi. 2024 Jul;49(14):3736-3748. doi: 10.19540/j.cnki.cjcmm.20240415.102. Zhongguo Zhong Yao Za Zhi. 2024. PMID: 39099348 Chinese.

8

[Treatment status of tyrosine kinase inhibitor for newly-diagnosed chronic myeloid leukemia: a domestic multi-centre retrospective real-world study].

Zhang XS, Liu BC, Du X, Zhang YL, Xu N, Liu XL, Li WM, Lin H, Liang R, Chen CY, Huang J, Yang YF, Zhu HL, Pan L, Wang XD, Li GH, Liu ZG, Zhang YQ, Liu ZF, Hu JD, Liu CS, Li F, Yang W, Meng L, Han YQ, Lin LE, Zhao ZY, Tu CQ, Zheng CF, Bai YL, Zhou ZP, Chen SN, Qiu HY, Yang LJ, Sun XL, Sun H, Zhou L, Liu ZL, Wang DY, Guo JX, Pang LP, Zeng QS, Suo XH, Zhang WH, Zheng YJ, Jiang Q. Zhang XS, et al. Among authors: hu jd. Zhonghua Xue Ye Xue Za Zhi. 2024 Mar 14;45(3):215-224. doi: 10.3760/cma.j.cn121090-20231108-00255. Zhonghua Xue Ye Xue Za Zhi. 2024. PMID: 38716592 Chinese.

9

The factors affecting the performance of the tunnel wall drilling task and their priority.

Gao PF, Zhi JY, Hu JD, Wang J, Xu YS, Zou R, Ding TC, Yang L. Gao PF, et al. Among authors: hu jd. Sci Rep. 2024 Apr 26;14(1):9564. doi: 10.1038/s41598-024-60381-3. Sci Rep. 2024. PMID: 38671037 Free PMC article.

10

[Correlation of miR-155 Expression with Drug Sensitivity of FLT3-ITD⁺ Acute Myeloid Leukemia Cell Line and Its Mechanism].

Wang LY, Jiang PF, Li JZ, Chen YX, Hu JD. Wang LY, et al. Among authors: hu jd. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2024 Apr;32(2):395-401. doi: 10.19746/j.cnki.issn.1009-2137.2024.02.011. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2024. PMID: 38660842 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

146 results

Search Page

Filters